11 July, 2014 | ChargePoint Technology
The presentation “Considerations for reducing risk and increasing containment performance” provides and introduction and insights for end users on how to introduce or improve contained powder handling in pharmaceutical manufacturing with a particular focus on the use split valve containment technology.
Slideshare: Considerations for reducing risk and increasing containment performance from ChargePoint Technology
About Michael Avraam
Michael Avraam has worked within the Pharmaceutical industry for over 18 years, primarily involved in the engineering, project management and sales of containment systems as well as filtration and drying equipment. He has extensive knowledge in the application of containment technology for high potency API production and formulation processes having worked with the majority of the leading pharmaceutical manufacturers in Europe, Asia and North America.